Home Inhaler Testing Aerodynamic Particle Size Distribution (APSD) APSD for Dry Powder Inhalers (DPIs)
The Aerodynamic Particle Size Distribution of a DPI will determine where the particles in the aerosol cloud are likely to deposit following inhalation. If the particles are too large they will catch at the back of the throat. Too small, and they will be exhaled rather than deposited.
The instrument of choice for measuring the APSD of DPI products to meet both regulatory and pharmacopoeial requirements alike is the cascade impactor.
There are five different cascade impactors/impingers suitable for the assessment of APSD, however, only the Andersen Cascade Impactor (ACI), the Next Generation Impactor (NGI) and the Multi-Stage Liquid Impinger (MSLI) appear in both the US and European Pharmacopoeias.
Please select an impactor:
We offer a range of training courses, presentations and seminars covering a wide range of topics....
Find Out MoreA comprehensive range of both in-house and on-site product servicing options are available...
Find Out MoreOur team of experienced technicians and engineers are on hand to help and advise ...
Find Out MoreLive-stream expert tuition to upskill and qualify staff, support IQ/OQ and optimise equipment use...
Find Out More20 April 2020; Nottingham, UK: Copley Scientific will shortly begin the company’s inaugural ser...
Find Out More28 February 2018; Nottingham, UK: Copley Scientific, a global leader in the design and manufactur...
Find Out More22nd August 2016; Nottingham, UK: Copley Scientific, the world’s leading manufacturer and suppl...
Find Out More30 June 2009; Nottingham, UK: New pinning kits from Copley Scientific provide users of cascade im...
Find Out MoreIn this article, João Pereira, Team Leader R&D Analytical Development, and Raquel Borda D’...
Find Out MoreOptimizing the role of automation in variability reduction strategies for delivered dose uniformi...
Find Out MoreThe regulatory landscape for OINDPs – the biggest shake-up in a generation?...
Find Out MoreVariability in cascade impaction: sources, impact and strategies for reduction...
Find Out MoreOptimizing the Application of In Vitro Test Methods for the Demonstration of Bioequivalence in Or...
Find Out MoreDemonstrating Bioequivalence of Orally Inhaled Products...
Find Out MoreOptimising the application of in vitro test methods for the demonstration of BE in OIPs...
Find Out MoreImproving the Realism and Relevance of Mouth-Throat Models for Inhaled Product Testing...
Find Out MoreHave a question? Our friendly and experienced team are here to help.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
Coronavirus – The latest update from Copley Scientific – |